MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

May 19, 2014

Phumeza Tisile, co-author of the DR-TB Manifesto and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide.

April 09, 2014

 

Geneva/New York—Patent barriers and high prices on oral treatments for hepatitis C could make it too expensive for developing countries to scale-up diagnosis and treatment of the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today. The warning comes as the World Health Organization (WHO) issued the first-ever guidelines for treatment of hepatitis C virus (HCV). 

March 06, 2014

Boston/New York, March 6, 2014—Two new studies released today by Epicentre,the research arm of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at CROI, the Conference on Retroviruses and Opportunistic Infections, point to reductions in new HIV infections in areas where HIV treatment has been greatly expanded. The studies are some of the first to look at large-scale antiretroviral therapy (ART) rollout in real-world high-HIV-burden settings in sub-Saharan Africa, and its possible impact on reducing new infections.

February 20, 2014

Despite minimal concessions, US demands remain extremely dangerous to all patients’ health across the Asia-Pacific region.

February 19, 2014

An anti-meningitis campaign in Benin delivers more than 150,000 doses with no losses from excess heat. View external media.

February 14, 2014

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provided oral testimony at a hearing of the U.S. International Trade Commission investigating India’s trade policies today in Washington, D.C.

February 13, 2014

This piece originally appeared on BMJ Group Blogs.

By Manica Balasegaram, executive director of the Doctors Without Borders/Médecins Sans Frontières (MSF) Access Campaign.

January 28, 2014

Judit Rius explains how the Trans-Pacific Partnership trade agreement would decrease access to affordable generic medications.

View external media

Pages